Prostatic Size Reduction Following of Leuprorelin Acetate
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18-95
SponsorConsorci Sanitari de Terrassa
About this trial
To determine the possible reduction in prostate size following the administration of Leuprelin prior to the application of radiotherapy.
Eligibility criteria
Qualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
- ACETATE LEUPRELINE
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov